Hims & Hers Health Inc (NYSE: HIMS) is 138.95% higher on its value in year-to-date trading and has touched a low of $13.47 and a high of $72.98 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HIMS stock was last observed hovering at around $48.42 in the last trading session, with the day’s gains setting it 0.54%.
Currently trading at $48.96, the stock is -5.78% and -4.80% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 30.51 million and changing 1.12% at the moment leaves the stock 39.65% off its SMA200. HIMS registered 102.48% gain for a year compared to 6-month gain of 94.29%. The firm has a 50-day simple moving average (SMA 50) of $51.427 and a 200-day simple moving average (SMA200) of $35.05845.
The stock witnessed a -7.22% loss in the last 1 month and extending the period to 3 months gives it a 88.38%, and is -1.79% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.93% over the week and 8.04% over the month.
Hims & Hers Health Inc (HIMS) has around 1637 employees, a market worth around $10.96B and $1.78B in sales. Current P/E ratio is 71.27 and Fwd P/E is 50.52. Profit margin for the company is 9.21%. Distance from 52-week low is 263.47% and -32.91% from its 52-week high. The company has generated returns on investments over the last 12 months (27.00%).
with sales reaching $550.06M over the same period.The EPS is expected to grow by 27.49% this year, but quarterly earnings will post 58.90% year-over-year. Quarterly sales are estimated to grow 74.26% in year-over-year returns.
Hims & Hers Health Inc (HIMS) Top Institutional Holders
585.0 institutions hold shares in Hims & Hers Health Inc (HIMS), with institutional investors hold 83.88% of the company’s shares. The shares outstanding are 215.21M, and float is at 190.70M with Short Float at 32.35%. Institutions hold 74.54% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 16.47 million shares valued at $332.55 million. The investor’s holdings represent 7.6746% of the HIMS Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 14.57 million shares valued at $294.25 million to account for 6.7907 of the shares outstanding. The other top investors are RENAISSANCE TECHNOLOGIES LLC which holds 6.04 million shares representing 2.814% and valued at over $121.94 million, while holds 2.4507 of the shares totaling 5.26 million with a market value of $106.19 million.
Hims & Hers Health Inc (HIMS) Insider Activity
Hims & Hers Health Inc disclosed in a document filed with the SEC on Jul 07 ’25 that Okupe Oluyemi (Chief Financial Officer) sold a total of 11,581 shares of the company’s common stock. The trade occurred on Jul 07 ’25 and was made at $46.67 per share for $0.54 million. Following the transaction, the insider now directly holds 58078.0 shares of the HIMS stock.
Still, SEC filings show that on Jun 30 ’25, Boughton Soleil (Chief Legal Officer) disposed off 2,572 shares at an average price of $50.50 for $0.13 million. The insider now directly holds 160,737 shares of Hims & Hers Health Inc (HIMS).
